Visit the Micromeritics web site
Click on the advert above to visit the company web site

Product category: Nucleic acid sequencing and synthesis
News Release from: Amaxa | Subject: Nucleofector
Edited by the Laboratorytalk Editorial Team on 04 April 2008

HudsonAlpha Institute adopts
Nucleofector

Request your FREE weekly copy of the Laboratorytalk email newsletter. News about Nucleic acid sequencing and synthesis and more every issue. Click here for details.

The HudsonAlpha Institute for Biotechnology will utilise Amaxa's Nucleofector technology as a core technology in certain research projects

One of the earliest projects will focus on a broad study across the NCI-60 cell line panel This technology will allow the HudsonAlpha Institute researchers to develop reproducible, non-viral based, optimised transfection protocols for the cell lines included in the National Cancer Institute's drug discovery panel

This will allow the study of gene control in the most extensively studied cell lines in the world.

"One of our goals is to develop high-throughput research tools that focus on why disease occurs and to rapidly apply this knowledge to help patients.

"To that end we recognize the need to understand cellular changes across many cell types.

"Amaxa's Nucleofector 96-well shuttle system is an important tool that will help provide the necessary capability," said Jim Hudson, president of the HudsonAlpha Institute.

"The HudsonAlpha Institute's comprehensive, high-throughput approach to research makes it an ideal collaborative partner for amaxa's technology.

"It is our goal to enable our customers to genetically manipulate whatever cell types they consider the best experimental model.

"This collaboration is a natural outcome of aligned objectives," said Rainer Christine, co-founder and CEO, Amaxa.

Amaxa: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Micromeritics web site